NEW YORK (GenomeWeb News) – The stock of Quest Diagnostics this week was downgraded by Zacks Equity Research to Underperform. In a statement, the investment research and information firm noted a drop in Quest's revenues and earnings-per-share for continuing operations in the fourth quarter, as well as a "disappointing outlook" for the first quarter of 2013.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.